TrialAmerican journal of hematology2020

Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia.

Elizabeth F Krakow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.